ImmunoPrecise Antibodies Ltd (IPA)
0.376
+0.03
(+7.92%)
USD |
NASDAQ |
Nov 22, 16:00
0.393
+0.02
(+4.52%)
After-Hours: 20:00
ImmunoPrecise Antibodies Shares Outstanding: 27.92M for Sept. 13, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
September 13, 2024 | 27.92M |
July 31, 2024 | 27.30M |
July 29, 2024 | 27.30M |
July 24, 2024 | 27.30M |
April 30, 2024 | 26.94M |
March 14, 2024 | 26.32M |
January 31, 2024 | 26.32M |
December 14, 2023 | 26.32M |
December 08, 2023 | 26.32M |
October 31, 2023 | 25.05M |
October 03, 2023 | 25.05M |
September 14, 2023 | 25.05M |
July 31, 2023 | 25.05M |
July 10, 2023 | 25.05M |
April 30, 2023 | 25.05M |
March 15, 2023 | 24.94M |
December 15, 2022 | 24.94M |
November 17, 2022 | 24.94M |
September 14, 2022 | 24.84M |
July 27, 2022 | 24.84M |
April 30, 2022 | 24.48M |
April 13, 2022 | 23.54M |
March 16, 2022 | 19.46M |
December 10, 2021 | 19.43M |
October 04, 2021 | 19.37M |
Date | Value |
---|---|
September 08, 2021 | 19.35M |
July 27, 2021 | 19.23M |
April 30, 2021 | 19.17M |
March 17, 2021 | 19.08M |
February 10, 2021 | 18.67M |
February 08, 2021 | 18.42M |
December 18, 2020 | 16.81M |
November 23, 2020 | 16.76M |
November 17, 2020 | 16.76M |
October 31, 2020 | 16.76M |
September 28, 2020 | 16.00M |
July 31, 2020 | 14.81M |
May 08, 2020 | 13.98M |
April 30, 2020 | 13.98M |
March 31, 2020 | 13.85M |
March 01, 2020 | 13.60M |
January 31, 2020 | 13.60M |
October 31, 2019 | 13.60M |
July 31, 2019 | 13.60M |
April 30, 2019 | 13.59M |
January 31, 2019 | 13.44M |
October 31, 2018 | 13.42M |
October 29, 2018 | 13.44M |
September 28, 2018 | 13.17M |
July 31, 2018 | 11.29M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
13.60M
Minimum
Jan 31 2020
27.92M
Maximum
Sep 13 2024
21.52M
Average
24.01M
Median
Shares Outstanding Benchmarks
Aurinia Pharmaceuticals Inc | 143.18M |
Edesa Biotech Inc | 3.247M |
Lexaria Bioscience Corp | 15.81M |
Xenon Pharmaceuticals Inc | 76.24M |
ESSA Pharma Inc | 44.37M |